Pharmacist Groups Applaud Introduction of Bill Expanding Medicare Patients’ Access to Pharmacist Services

Published: May 11, 2023
ASHP Press Release

ASHP and the American Pharmacists Association (APhA) today applauded the introduction of legislation that would give tens of millions of Medicare patients in medically underserved communities access to critically needed patient care services delivered by pharmacists.

The Pharmacy and Medically Underserved Areas Enhancement Act was introduced  by Sens. Charles Grassley (R-IA), Sherrod Brown (D-OH), Bob Casey (D-PA), Cindy Hyde-Smith (R-MS), and Ben Ray Luján (D-NM). The bill would enable pharmacists to deliver Medicare Part B services that are already authorized by their respective state laws. These services may include:

  • Medication management
  • Management of chronic conditions, such as diabetes and hypertension, and related medications
  • Cholesterol testing
  • Point-of-care testing (e.g., COVID-19, influenza, strep)
  • Immunization screening and administration not currently covered by Medicare Parts B and D
  • Tobacco cessation services
  • Transition of care services

“Patients living in medically underserved communities often struggle to access the care they need, and pharmacists have proven to be an essential source of care for these patients,” said Ilisa BG Bernstein, PharmD, JD, FAPhA, Interim Executive Vice President and CEO of APhA, and Paul W. Abramowitz, PharmD, ScD (Hon), FASHP, CEO of ASHP. “This important legislation helps ensure seniors living in rural and other underserved communities have improved access to the care they need from a pharmacist they trust. As pharmacists, we are grateful to Senators Grassley, Brown, Casey, Hyde-Smith, and Luján for their leadership in addressing gaps in access to pharmacist care.”



State governments are increasingly calling on pharmacists to provide patients with access to essential healthcare services—from point-of-care testing to patient counseling and administration of certain drugs. The legislation brings Medicare rules in alignment with existing authorities already granted to pharmacists by many states and healthcare organizations through credentialing and privileging programs. Forty-three states have Medicaid programs that recognize pharmacists, and all 50 states have expanded pharmacists' ability to provide care.

Pharmacists have advanced education and training to deliver these services and are one of the most accessible healthcare providers in the nation. Pharmacists earn a Doctor of Pharmacy (PharmD) degree that includes six to eight years of higher education. Many pharmacists also complete one to two years of post-graduate residency training and become certified in a specialty by the Board of Pharmacy Specialties. Numerous studies show that pharmacists improve patient outcomes, expand access to care, and contribute to cost savings.

About ASHP

ASHP is the largest association of pharmacy professionals in the United States, representing 60,000 pharmacists, student pharmacists, and pharmacy technicians in all patient care settings, including hospitals, ambulatory clinics, and health-system community pharmacies. For over 80 years, ASHP has championed innovation in pharmacy practice, advanced education and professional development, and served as a steadfast advocate for members and patients. In addition, ASHP is the accrediting body for pharmacy residency and technician training programs and provides comprehensive resources to support pharmacy professionals through every stage of their careers. For more information, visit and ASHP’s consumer website,

Posted May 11, 2023

Advance Your Professional Development

View Other Products

Free Board Exam Prep Resources

The Review & Recertification Reward Program (RRRP) includes free access to exam preparation material + enrollment in a recertification plan billed monthly ($10) during your initial recertification cycle. For ASHP members only.

Learn More
Review & Recertification Reward Program (RRRP)

New Edition Available to Order

AHFS Drug Information® 2024 contains the most dependable drug information available—all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.

Order Today
AHFS 2024 Drug Information